| Application no. and date | 10186086.4 (espacenet) (Federated) (European Patent Register), 20030320 | | Patent/reg. no. and date | DK/EP 2295055, 20170607 | | Publication date | 20110316 | | Priority no. and date | US 366515 P, 20020320, US 438450 P, 20030107 | | EP pub. no. and date |
EP 2295055 20110316 | | Effective date | | | Applicant/owner | Amgen (Europe) GmbH, Floor 6-8
Suurstoffi 22
Risch-Rotkreuz 6343, CH | | Applicant ref. no. | P61982DK02 | | Inventor | Man, Hon-wah, 27 Grant Way
Princeton, NJ 08540, US,
GE, Chuansheng, 9 Breckenridge Court
Belle Mead, NJ 08502, US,
SCHAFER, Peter H., 237 Monroe Avenue
Belle Mead, NJ 08502, US,
Muller, George W., P.O. Box 3688
Rancho Sante Fe, CA 92067, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/4035 (2006.01) , A61P 37/00 (2006.01) , C07C 317/28 (2006.01) , C07D 209/48 (2006.01) | | Title | (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindolin-1,3-dion: Fremgangsmåder til anvendelse og sammensætninger deraf | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
